Compare ZDGE & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZDGE | INMB |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | 55 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9M | 39.6M |
| IPO Year | 2016 | 2018 |
| Metric | ZDGE | INMB |
|---|---|---|
| Price | $3.03 | $1.92 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 109.0K | ★ 1.1M |
| Earning Date | 06-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ 73.85 | 11.85 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $29,398,000.00 | $50,000.00 |
| Revenue This Year | $3.27 | N/A |
| Revenue Next Year | $5.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $2.21 | $1.09 |
| 52 Week High | $4.70 | $3.24 |
| Indicator | ZDGE | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 62.45 |
| Support Level | $2.89 | $1.77 |
| Resistance Level | $3.16 | $2.30 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 15.79 | 66.89 |
Zedge Inc builds digital marketplaces and competitive games centered on content that people use for self-expression. Its products include the Zedge App, a freemium digital content marketplace offering mobile wallpapers, video wallpapers, ringtones, and notification sounds, along with pAInt, a generative AI wallpaper and ringtone maker, GuruShots, a skill-based photo challenge game, and Emojipedia, a trusted source for emoji information. The Zedge App is available on Google Play and the App Store. The company operates two segments: Zedge Marketplace and GuruShots, with the majority of revenue generated from the Zedge Marketplace.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.